Fluor (FLR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
Q3 2024 revenue reached $4.1 billion, with consolidated new awards of $2.7 billion and a backlog of $31.3 billion, 75% from non-traditional oil and gas projects.
Adjusted EBITDA for Q3 was $124 million, with adjusted EPS of $0.51; net earnings attributable to Fluor were $54 million.
Strong Q3 operating cash flow of $330 million, up from $3 million in Q3 2023, driven by JV distributions, customer payments, and IRS refunds.
NuScale deconsolidation in Q4 2024 will result in a $1.6 billion gain; Board increased share repurchase authorization to 30.5 million shares.
Backlog growth driven by large life sciences project awards and robust Urban Solutions performance.
Financial highlights
Q3 consolidated segment profit was $117 million, with a margin of 2.9%, impacted by lower Energy Solutions results.
General and administrative expenses dropped to $37 million from $56 million a year ago due to reduced incentive compensation.
Cash and marketable securities at quarter-end were $2.9 billion (excluding NuScale).
Adjusted EBITDA margin for Q3 was 3.0%.
Net earnings for Q3 were $54 million, down from $206 million in Q3 2023.
Outlook and guidance
2024 adjusted EPS guidance narrowed to $2.55–$2.75; adjusted EBITDA guidance lowered to $525–$575 million.
Full-year operating cash flow guidance raised to ~$700 million, up from $212 million in 2023.
Revenue growth for 2024 expected at ~10%, with G&A expenses of $200 million and an effective tax rate of 35–40%.
Segment margin guidance: ~4% for Energy Solutions and Urban Solutions, 6% for Mission Solutions.
2025 guidance and long-term value creation plans to be provided in February.
Latest events from Fluor
- Financial discipline, growth in Urban Solutions, and nuclear power drive a robust outlook.FLR
UBS Global Industrials and Transportation Conference8 Jul 2026 - Q2 revenue grew 7% to $4.2B, net earnings hit $169M, and backlog reached $32.3B.FLR
Q2 20248 Jul 2026 - Q3 2025 net loss of $697M from Santos and NuScale charges; adjusted EBITDA and EPS rose YoY.FLR
Q3 20258 Jul 2026 - Adjusted EBITDA up 76% year-over-year; 2025 guidance held despite $241M GAAP net loss.FLR
Q1 20258 Jul 2026 - Q1 2026 delivered $3.66B revenue, $160M net earnings, and strong cash flow with a $25.7B backlog.FLR
Q1 202611 May 2026 - Strong financials, leadership changes, and all proposals approved amid strategic growth focus.FLR
AGM 20266 May 2026 - 2026 guidance targets higher earnings and margins, with $754M in share repurchases in 2025.FLR
Q4 202511 Apr 2026 - Board refreshment, pay-for-performance, and strong risk oversight headline this year's proxy.FLR
Proxy Filing12 Mar 2026 - Votes will be cast on board nominees, executive pay, and auditor ratification for 2026.FLR
Proxy Filing12 Mar 2026